ProAssurance (PRA) Proxy Filing summary

Executive summary

• Special meeting called for shareholders to vote on a merger agreement with The Doctors Company, making the company a wholly owned subsidiary and providing $25.00 per share in cash, a 58.8% premium over the pre-announcement price.

• The board unanimously recommends voting in favor of the merger, the executive compensation proposal, and the adjournment proposal.

• The merger is expected to close in the first half of 2026, subject to regulatory and shareholder approvals.

Voting matters and shareholder proposals

• Shareholders will vote on: (1) adoption of the merger agreement, (2) a non-binding advisory vote on executive compensation related to the merger, and (3) a proposal to adjourn the meeting if more votes are needed.

• Approval of the merger requires a majority of outstanding shares; the other proposals require a majority of shares present or represented by proxy.

• Dissenting shareholders may seek appraisal rights under Delaware law.

Board of directors and corporate governance

• The board formed a transaction committee to oversee negotiations and strategic alternatives.

• The board conducted a strategic review, contacted potential acquirers, and determined the merger consideration was the highest reasonably obtainable.

• Post-merger, the board of the surviving corporation will consist of Merger Sub’s directors; current officers will continue.